Beta-cell mass (BCM)and the functional state of islets are critical measures in assessing the magnitude of autoimmune destruction in type 1 diabetes. Progressive loss of BCM is also responsible for the secondary failure of currently available drugs (lack of durability) in type 2 diabetes. Serum tests such as insulin/C- peptide and others do not reliably measure BCM,and currently the only accepted gold standard of measurement is autopsy. It is generally believed that imaging could ultimately be used to a) better understand the history of the islet and the pathophysiology of diabetes, b) enable earlier diagnosis of type 1 diabetes (T1DM), c) allow monitoring of therapeutic efficacy and durability (including islet transplantation), and d) reveal image-able biomarkers useful in the discovery of new therapies. Unfortunately, the necessary tools to quantify BCM are still largely missing. The overall goal of this project is therefore to develop novel in vivo imaging methods and agents with specificity for p-cells, in order to non-invasively visualize the target of autoimmune attack in type 1 diabetes. This will be done using powerful library, small-molecule combinatorial and genetic approaches. In close collaboration with the Mathis and Benoist groups, we will validate the most promising agents using accepted gold standards and mouse models. Specifically, we will ask the following questions: 1) what is the in vivo behavior and the putative binding partners of the new affinity ligands ? 2) what is the correlation between imaging signal and BCM ? and 3) what are the sources of error in measurements, and how can they be reduced ? The progress to date (newfluorescent mouse models, imaging techniques such as FPT and IVM and new leads from screens to be converted into imaging agents) has been remarkable. The developed agents and strategies will be designed to be clinically translatable, and should add to our previously developed clinical data on imaging islet dysfunction.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI054904-10
Application #
8512643
Study Section
Special Emphasis Panel (ZAI1-SV-I)
Project Start
Project End
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
10
Fiscal Year
2013
Total Cost
$521,178
Indirect Cost
$67,218
Name
Harvard University
Department
Type
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Stangenberg, Lars; Burzyn, Dalia; Binstadt, Bryce A et al. (2014) Denervation protects limbs from inflammatory arthritis via an impact on the microvasculature. Proc Natl Acad Sci U S A 111:11419-24
Hedgire, Sandeep S; McDermott, Shaunagh; Wojtkiewicz, Gregory R et al. (2014) Evaluation of renal quantitative T2* changes on MRI following administration of ferumoxytol as a T2* contrast agent. Int J Nanomedicine 9:2101-7
Dirice, Ercument; Kahraman, Sevim; Jiang, Wenyu et al. (2014) Soluble factors secreted by T cells promote *-cell proliferation. Diabetes 63:188-202
Clardy, Susan M; Keliher, Edmund J; Mohan, James F et al. (2014) Fluorescent exendin-4 derivatives for pancreatic *-cell analysis. Bioconjug Chem 25:171-7
Morton, Angela M; Sefik, Esen; Upadhyay, Rabi et al. (2014) Endoscopic photoconversion reveals unexpectedly broad leukocyte trafficking to and from the gut. Proc Natl Acad Sci U S A 111:6696-701
Carlson, Jonathan C T; Meimetis, Labros G; Hilderbrand, Scott A et al. (2013) BODIPY-tetrazine derivatives as superbright bioorthogonal turn-on probes. Angew Chem Int Ed Engl 52:6917-20
Keliher, Edmund J; Reiner, Thomas; Earley, Sarah et al. (2013) Targeting cathepsin E in pancreatic cancer by a small molecule allows in vivo detection. Neoplasia 15:684-93
Robbins, Clinton S; Hilgendorf, Ingo; Weber, Georg F et al. (2013) Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med 19:1166-72
Engin, Feyza; Yermalovich, Alena; Nguyen, Truc et al. (2013) Restoration of the unfolded protein response in pancreatic * cells protects mice against type 1 diabetes. Sci Transl Med 5:211ra156
Fu, Wenxian; Wojtkiewicz, Gregory; Weissleder, Ralph et al. (2012) Early window of diabetes determinism in NOD mice, dependent on the complement receptor CRIg, identified by noninvasive imaging. Nat Immunol 13:361-8

Showing the most recent 10 out of 25 publications